New Twist on Health: Modified Citrus Pectin for Cancer, Heart Disease and More, By Karolyn Gazella
Put the Squeeze on Disease
Years ago, a handful of integrative doctors began using Modified Citrus Pectin (MCP) to fight cancer and other degenerative conditions. That’s because a number of peer-reviewed studies confirmed what practitioners were observing: MCP offers significant health benefits in fighting cancer and other diseases while improving quality of life.
Now, more than 20 years later, extensive research on the rogue protein and aging biomarker galectin-3 (Gal-3) shows exactly how MCP works: by binding to excess Gal-3 and blocking its harmful effects. In fact, a low molecular weight MCP is now recognized in the scientific literature as the most researched Gal-3 inhibitor, with significant research supporting the reduction of heart disease, cancer, chronic inflammation and fibrosis.
Follow veteran health writer and cancer survivor Karolyn Gazella as she takes readers on a journey through the history of this humble ingredient, the research on Gal-3, and the numerous conditions that MCP can help treat:
- Metastatic cancer
- Kidney and liver disease
- Cardiovascular disease and heart failure
- Chronic inflammation and fibrosis
- and more…